These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Clavin NW; Avraham T; Fernandez J; Daluvoy SV; Soares MA; Chaudhry A; Mehrara BJ Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2113-27. PubMed ID: 18849330 [TBL] [Abstract][Full Text] [Related]
28. Primary Upper Limb Lymphedema: Case Report of a Rare Pathology. Mcfarlane ME Perm J; 2017; 21():16-010. PubMed ID: 28080951 [TBL] [Abstract][Full Text] [Related]
29. [Metabolism of hyaluronic acid and extremity lymphedema]. Liu NF; Zhang LR; Li SL; Cao WG; Zhang DS; Cao YL Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Mar; 20(2):113-6. PubMed ID: 15334933 [TBL] [Abstract][Full Text] [Related]
30. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Haiko P; Makinen T; Keskitalo S; Taipale J; Karkkainen MJ; Baldwin ME; Stacker SA; Achen MG; Alitalo K Mol Cell Biol; 2008 Aug; 28(15):4843-50. PubMed ID: 18519586 [TBL] [Abstract][Full Text] [Related]
35. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D. Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824 [TBL] [Abstract][Full Text] [Related]
36. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing. Ji RC; Miura M; Qu P; Kato S Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895 [TBL] [Abstract][Full Text] [Related]
37. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study. Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927 [TBL] [Abstract][Full Text] [Related]
38. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
39. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Chan ES; Fernandez P; Merchant AA; Montesinos MC; Trzaska S; Desai A; Tung CF; Khoa DN; Pillinger MH; Reiss AB; Tomic-Canic M; Chen JF; Schwarzschild MA; Cronstein BN Arthritis Rheum; 2006 Aug; 54(8):2632-42. PubMed ID: 16871530 [TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Yasuoka H; Jukic DM; Zhou Z; Choi AM; Feghali-Bostwick CA Arthritis Rheum; 2006 Sep; 54(9):3001-10. PubMed ID: 16947625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]